Factors Indicating Against Dose Escalation Maintain current dose when experiencing significant side effects at present level, achieving satisfactory subjective improvements (better sleep, energy, recovery), IGF-1 increased adequately (50+ ng/mL) for optimization goals, or financial constraints make higher dosing unsustainable
Consistency remains keymany people who see limited initial results may experience better outcomes with continued use at the appropriate dose, combined with supportive lifestyle practices
Impact of climate change on sheep reproduction
Side effects such as nausea, diarrhea, and abdominal discomfort are common but usually manageable
See 21 CFR 50.3 An Institutional review board (IRB) means any board, committee, or other group formally designated by an institution to review biomedical research involving humans as subjects, to approve the initiation of and conduct periodic review of such research